Fig. 5From: Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsiesA Decision curve analysis (DCA) for the models for predicting csPCa in the development cohort. B DCA for the models for predicting csPCa in validation cohort 1. C DCA for the models for predicting csPCa in validation cohort 2. csPCa = Clinically significant prostate cancer; DCA = Decision curve analysisBack to article page